Evidence map›Paper›PMID 36142052›Full record

ArticleInternational journal of environmental research and public health2022

Hysteroscopic Resection Followed by Adjuvant Radiotherapy: Report of a New Therapeutic Approach to Primary Cervical Diffuse Large B-Cell Lymphoma.

Guglielmo Stabile, Lara Sancin, Pierino Boschian Bailo, Chiara Ripepi, Andrea Romano, Stefania Carlucci, Giuseppe Ricci

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Guglielmo StabileInstitute for Maternal and Child Health-IRCCS "Burlo Garofolo", Department of Obstetrics and Gynaecology, 34137 Trieste, Italy.ORCID 0000-0001-9266-3896
Lara SancinDepartment of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy.
Pierino Boschian BailoDepartment of Obstetrics and Gynecology, Azienda Sanitaria Universitaria Giuliano-Isontina, San Polo Hospital, Gorizia-Monfalcone, 34149 Trieste, Italy.
Chiara RipepiDepartment of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy.
Andrea RomanoDepartment of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy.
Stefania CarlucciDepartment of Obstetrics and Gynecology, Azienda Sanitaria Universitaria Giuliano-Isontina, San Polo Hospital, Gorizia-Monfalcone, 34149 Trieste, Italy.
Giuseppe RicciInstitute for Maternal and Child Health-IRCCS "Burlo Garofolo", Department of Obstetrics and Gynaecology, 34137 Trieste, Italy.ORCID 0000-0002-8031-1102
University of Trieste · ITOspedale San Paolo · ITIRCCS Materno Infantile Burlo Garofolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The female genital tract can be involved as a secondary manifestation of disseminated lymphomas or leukemia but can rarely be the primary site of so-called extranodal lymphomas. Primary lymphomas of the female genital tract can affect the uterine corpus, uterine cervix, vulva, vagina or adnexa. Only about 0.008% of all cervical tumors are primary malignant lymphomas. The presenting symptoms are unspecific and also refer to much more common diseases of the female genital tract. Cervical cytology is usually negative. Preoperative diagnosis requires deep cervical biopsy. To date there is no consensus regarding optimal treatment. Radiotherapy, chemotherapy and surgery are used in different association. We report the first case reported in literature managed with an urgent hysteroscopic resection of a primary cervical diffuse large B-cell lymphoma, followed by adjuvant radiotherapy. Relevant literature was reviewed. Our conservative approach needs to be validated in the future, especially for women with pregnancy desire and for those with low performance status. To date, after 24 months from diagnosis, our patient is still disease-free.

Indexed as

Lymphoma, Large B-Cell, DiffuseUterine Cervical NeoplasmsFemaleHumansRadiotherapy, Adjuvantcervical cancerconservative treatmenthysteroscopylymphomaminimally invasive approach

Identifiers

PMID36142052
PMCPMC9517014
OpenAlexW4296353933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.